Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Galectin Therapeutics Inc (GALT) operate in?
Galectin Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Galectin Therapeutics Inc (GALT) current stock price?
As of the latest data, Galectin Therapeutics Inc stock price is $4.41, with a previous close of $4.50. Galectin Therapeutics Inc lost -$0.09 in the last trading session, representing a -2% loss.
What is Galectin Therapeutics Inc (GALT) current market capitalization?
Galectin Therapeutics Inc market cap is approximately 279.12 million.
What is Galectin Therapeutics Inc (GALT) Earnings Per Share (EPS)?
The trailing EPS is -$0.64.
Does Galectin Therapeutics Inc (GALT) pay dividends?
No. Galectin Therapeutics Inc does not pay a dividend.
When is Galectin Therapeutics Inc (GALT) next earnings report?
Galectin Therapeutics Inc is expected to release its next earnings report on September 30, 2025.
What is Galectin Therapeutics Inc (GALT) beta (volatility) score?
Galectin Therapeutics Inc has a beta of 0.827, meaning its volatility is roughly in line with the market.